Chuanfa Liu

State Key Laboratory Of Digestive Disease
Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity.

Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity.

Journal: Cell host & microbe

Published: September 03, 2025

Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity.

Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity.

Journal: Cell host & microbe

Published: July 22, 2025

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.

Journal: Cancer cell

Published: March 11, 2025

Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.

Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.

Journal: Nature metabolism

Published: January 21, 2025

Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity.

Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity.

Journal: Cell host & microbe

Published: December 16, 2024

Multi-cohort analysis reveals colorectal cancer tumor location-associated fecal microbiota and their clinical impact.

Multi-cohort analysis reveals colorectal cancer tumor location-associated fecal microbiota and their clinical impact.

Journal: Cell host & microbe

Published: October 21, 2024

Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.

Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.

Journal: Nature metabolism

Published: September 18, 2023

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.

Journal: Cancer cell

Published: April 12, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026